日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma

塞利尼索联合免疫检查点阻断疗法治疗晚期肾细胞癌患者的 IB 期试验

Alhalabi, Omar; Gouda, Mohamed A; Milton, Denái R; Momin, Hassan Ahmed; Yilmaz, Bulent; Stephen, Bettzy; Ejezie, Chinenye Lynette; Moyers, Justin Tyler; Gurses, Serdar A; How, Jeffrey; Fu, Siqing; Rodon, Jordi; Hong, David S; Piha-Paul, Sarina A; Subbiah, Vivek; Elena Dumbrava, Ecaterina; Karp, Daniel D; Janku, Filip; Meric-Bernstam, Funda; Tannir, Nizar M; Naing, Aung

Predicting multiple sclerosis prognosis using AI and machine learning: integrating clinical, immunological, and radiological variables

利用人工智能和机器学习预测多发性硬化症预后:整合临床、免疫学和放射学变量

Al-Shammri, Suhail; Özdil, Ahmet; Aboukoura, Amro; Azizieh, Fawaz; Yilmaz, Bulent; Raghupathy, Raj

Modeling and simulation of an effectual triangular slotted UWB flexible antenna for breast cancer detection and healthcare monitoring

对一种用于乳腺癌检测和健康监测的有效三角形开槽超宽带柔性天线进行建模和仿真

Singh, Aparna; Dwivedi, R K; Singh, Vinod Kumar; Sharma, Manish; Sharma, Kanhaiya; Yilmaz, Bulent

Comparison of Serum and Cervical Mucus Docosahexaenoic Acid (DHA) Levels in Patients with Polycystic Ovary Syndrome and Healthy Controls

多囊卵巢综合征患者与健康对照组血清和宫颈粘液中二十二碳六烯酸(DHA)水平的比较

Bayrak, Cigdem Can; Yilmaz, Bulent; Kagitci, Mehmet; Ince, Onur; Mataraci Karakas, Sibel; Yilmaz, Adnan

A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma

塞利尼索联合帕博利珠单抗治疗转移性黑色素瘤患者的 Ib 期研究

Gouda, Mohamed A; Stephen, Bettzy; Tian, Yanyan; Alshawa, Anas; Onwugaje, Dilichukwu O Chudy; Albittar, Aya; Yang, Yali; Zarifa, Abdulrazzak; Yilmaz, Bulent; Gurses, Serdar; Sprenger, Ashabari; Derbala, Mohamed H; Brink, Amanda; How, Jeffrey Andrew; Moyers, Justin; Piha-Paul, Sarina A; Hong, David S; Meric-Bernstam, Funda; Patel, Sapna P; Oliva, Isabella Glitza

Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.

sapanisertib (CB-228/TAK-228/MLN0128) 与 ziv-aflibercept 联合治疗晚期实体瘤患者的 I 期研究

Coleman Niamh, Stephen Bettzy, Fu Siqing, Karp Daniel, Subbiah Vivek, Ahnert Jordi Rodon, Piha-Paul Sarina A, Wright John, Fessahaye Senait N, Ouyang Fengying, Yilmaz Bulent, Meric-Bernstam Funda, Naing Aung

Effects of external neuromuscular electrical stimulation in women with urgency urinary incontinence: a randomized sham-controlled study

外部神经肌肉电刺激对女性急迫性尿失禁的影响:一项随机假刺激对照研究

Kurt, Tugba Birben; Yilmaz, Bulent; Celenay, Seyda Toprak

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer

塞利尼索联合帕博利珠单抗治疗转移性非小细胞肺癌的安全性、耐受性和临床活性

Altan, Mehmet; Tu, Janet; Milton, Denái R; Yilmaz, Bulent; Tian, Yanyan; Fossella, Frank V; Mott, Frank E; Blumenschein, George R; Stephen, Bettzy; Karp, Daniel D; Meric-Bernstam, Funda; Heymach, John V; Naing, Aung

Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer

一项评估塞利尼索和艾立布林联合治疗晚期实体瘤和三阴性乳腺癌的1b期研究

Nelson, Blessie Elizabeth; Saleem, Sadia; Damodaran, Senthil; Somaiah, Neeta; Piha-Paul, Sarina; Moore, Julia Ann; Yilmaz, Bulent; Ogbonna, Deby; Karp, Daniel D; Dumbrava, Ecaterina; Tsimberidou, Apostolia M; Hong, David S; Rodon Ahnert, Jordi; Milton, Denái R; Zheng, Xiaofeng; Booser, Daniel J; Ibrahim, Nuhad K; Conley, Anthony P; Bhosale, Priya; Rojas Hernandez, Cristhiam M; Tripathy, Debasish; Naing, Aung; Meric-Bernstam, Funda

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience

免疫检查点抑制剂在癌症合并病毒性肝炎患者中的安全性和有效性:MD安德森癌症中心的经验

Nardo, Mirella; Yilmaz, Bulent; Nelson, Blessie Elizabeth; Torres, Harrys A; Wang, Lan Sun; Granwehr, Bruno Palma; Song, Juhee; Dalla Pria, Hanna R F; Trinh, Van A; Glitza Oliva, Isabella C; Patel, Sapna P; Tannir, Nizar M; Kaseb, Ahmed Omar; Altan, Mehmet; Lee, Sunyoung S; Miller, Ethan; Zhang, Hao; Stephen, Bettzy A; Naing, Aung